Global Pet Diabetes Care Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Device;
Insulin Delivery Devices, Insulin Delivery Pen, Insulin Syringes, and Glucose Monitoring Devices.By Animal Type;
Cats, Dogs, and Horses.By End-Use;
Veterinary Clinics, Home Care Settings, and Veterinary Hospitals.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Pet Diabetes Care Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Pet Diabetes Care Devices Market was valued at USD 2,386.27 million. The size of this market is expected to increase to USD 4,224.03 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.5%.
The Global Pet Diabetes Care Devices Market is a rapidly growing segment within the broader pet care industry, driven by the increasing prevalence of diabetes among pets, particularly dogs and cats. As pets live longer and their health concerns become more complex, conditions such as diabetes are becoming more common, particularly in aging pets or those with underlying health issues such as obesity. Pet diabetes, especially insulin-dependent diabetes, requires ongoing management to ensure pets lead healthy, active lives. The market for diabetes care devices is thus expanding as more pet owners seek effective, reliable, and user-friendly solutions to monitor and manage their pets' blood glucose levels. These devices, which include blood glucose meters, insulin pumps, continuous glucose monitors (CGMs), and other related technologies, offer pet owners the tools they need to maintain their pets' health and avoid serious complications related to diabetes.
Advancements in diabetes care technology are contributing to the growth of the market, with innovations that provide greater accuracy, ease of use, and convenience for pet owners. Devices like glucose monitoring systems and insulin pumps are becoming increasingly sophisticated, enabling more precise treatment and reducing the risk of diabetes-related complications in pets. For instance, pet owners can now use advanced blood glucose monitors designed specifically for pets, which feature pet-friendly features like smaller blood sample sizes and pet-specific readings. Additionally, the growing awareness of the importance of early detection and monitoring is prompting more pet owners to seek out regular testing and better management solutions. This growing focus on preventive care is helping to normalize the use of medical devices in managing chronic conditions like diabetes, increasing their acceptance and adoption among pet owners.
As the global pet care market continues to evolve, the increasing emphasis on pet health and wellness is providing a significant push for the diabetes care devices market. Rising pet ownership, particularly among millennial and Gen Z pet parents, who view their pets as family members, is driving demand for high-quality, personalized, and comprehensive care solutions. These pet owners are more likely to invest in products that ensure their pets' long-term health, including devices for chronic conditions like diabetes. Additionally, the increasing availability of veterinary services, the rising trend of pet insurance, and improved access to specialized medical care for pets further fuel the adoption of diabetes management devices. The market is expected to continue growing as both pet owners and veterinarians increasingly prioritize the long-term well-being of diabetic pets, contributing to the overall expansion of the Global Pet Diabetes Care Devices Market.
Global Pet Diabetes Care Devices Market Recent Developments
-
In 2020, Zoetis Inc. introduced alpha TRAK 2, a new blood glucose monitoring system designed specifically for pets.
-
In 2020, Abbott Laboratories launched the FreeStyle Libre 2 system, a glucose monitoring solution suitable for both pets and humans.
Segment Analysis
The Global Pet Diabetes Care Devices Market can be analyzed based on various product segments, including blood glucose monitors, insulin pumps, continuous glucose monitoring systems (CGMs), and diabetes management accessories. Blood glucose monitors remain one of the most popular products in this segment, driven by their ability to offer quick and accurate blood glucose readings for pets. These devices are essential for pet owners to monitor their diabetic pets’ blood sugar levels at home and make adjustments to their insulin administration. The growing adoption of home-based blood glucose monitoring solutions is helping to ease the management of diabetes for pets, especially as they become more advanced and user-friendly. This segment continues to expand as pet owners increasingly prefer non-invasive or minimally invasive methods to track their pets’ health without frequent vet visits.
The insulin pump segment is another key component of the pet diabetes care market, providing an automated way to administer insulin to diabetic pets. Insulin pumps offer significant advantages, including better regulation of blood sugar levels and a reduction in the frequency of injections, which is particularly beneficial for pets that require long-term insulin therapy. As technology continues to improve, insulin pumps designed specifically for pets are becoming more reliable, accurate, and easier to use. This segment is expected to see steady growth as more pet owners seek solutions that offer greater control over their pets' diabetes and improve their overall quality of life. However, the high cost of insulin pumps, as well as the complexity of their use, may limit their adoption among some pet owners.
The continuous glucose monitoring systems (CGMs) represent an emerging segment in the pet diabetes care market, offering real-time, continuous monitoring of glucose levels without the need for frequent blood tests. These systems provide significant advantages for managing diabetes in pets by offering real-time data, which allows for quicker adjustments to insulin administration and better overall control of blood glucose levels. CGMs are particularly appealing for pet owners who want to reduce the number of invasive procedures their pets undergo. As the technology becomes more refined and affordable, the adoption of CGMs in the pet care industry is expected to rise. Alongside these devices, diabetes management accessories such as insulin syringes, test strips, and lancets also contribute to market growth, supporting the overall diabetes care process. These products, although small in scale, play an essential role in the daily management of diabetic pets, contributing to the market’s expansion across various regions.
Global Pet Diabetes Care Devices Segment Analysis
In this report, the Global Pet Diabetes Care Devices Market has been segmented by Device, Animal Type, End-Use and Geography.
Global Pet Diabetes Care Devices Market, Segmentation by Device
The Global Pet Diabetes Care Devices Market has been segmented by Device into Insulin Delivery Devices, Insulin Delivery Pen, Insulin Syringes, and Glucose Monitoring Devices.
The Global Pet Diabetes Care Devices Market is primarily segmented by device type into insulin delivery devices, insulin delivery pens, insulin syringes, and glucose monitoring devices. Insulin delivery devices are crucial for the management of insulin-dependent diabetes in pets, allowing for precise and controlled administration of insulin. These devices, which include insulin pumps, are typically used to deliver continuous or intermittent insulin doses to pets with diabetes. The main advantage of insulin pumps is their ability to provide a steady, controlled release of insulin, which helps maintain stable blood glucose levels in pets. This technology is particularly useful for pets with more complex diabetes management needs, as it reduces the number of injections required, improving both the pet's and owner’s experience.
Insulin delivery pens are another important device in this segment, offering a more convenient and user-friendly alternative to traditional syringes. These pens are designed for ease of use, with a dial for precise dosage and a disposable needle for each injection. Insulin delivery pens are gaining popularity among pet owners due to their portability, accuracy, and ease of administration, especially for pets that need regular insulin injections. The pens are particularly useful for smaller doses and can be used in home settings, providing convenience for pet owners who need to manage their pets' diabetes on a daily basis. As the pet diabetes care market continues to grow, insulin delivery pens are expected to see steady demand, particularly among pet owners who prefer a more straightforward and less invasive method of insulin administration.
The insulin syringes segment remains a significant part of the pet diabetes care market, especially in cases where insulin delivery pens and pumps may not be as suitable or affordable. Insulin syringes are simple to use, widely available, and offer an affordable option for pet owners who need to administer insulin regularly. These syringes are still one of the most common tools for insulin administration in diabetic pets, especially for those on tight budgets or for pet owners who prefer the familiarity of traditional syringes. In addition, glucose monitoring devices, including blood glucose meters, are essential tools in the management of diabetes in pets. These devices allow pet owners to monitor their pets' blood sugar levels at home, making it easier to adjust insulin doses and track the effectiveness of the treatment. As technology advances, glucose monitoring devices are becoming more accurate, user-friendly, and accessible, contributing to the growing adoption of these devices in the pet diabetes care market.
Global Pet Diabetes Care Devices Market, Segmentation by Animal Type
The Global Pet Diabetes Care Devices Market has been segmented by Animal Type into Cats, Dogs, and Horses.
he Global Pet Diabetes Care Devices Market is segmented by animal type into cats, dogs, and horses, with each group exhibiting unique needs and requirements for diabetes management. Cats are one of the most common pets diagnosed with diabetes, especially as they age, and are particularly susceptible to type 2 diabetes. In cats, diabetes management often requires insulin injections or the use of insulin pumps, alongside regular glucose monitoring. Due to the relatively smaller size and more sensitive nature of cats, glucose monitoring devices tailored specifically for them are crucial for accurate readings and effective management. With the increasing awareness of diabetes in cats and the availability of specialized care devices, the market for diabetes care solutions for felines is expected to grow steadily, driven by the growing focus on preventative health and the long-term management of chronic conditions.
The dogs segment is the largest and most lucrative in the pet diabetes care devices market, as dogs are commonly diagnosed with diabetes, particularly in their senior years or in cases of obesity. Dogs with diabetes require regular monitoring of their blood glucose levels, insulin injections, or the use of insulin delivery devices such as insulin pumps. The demand for both insulin delivery devices and glucose monitoring systems is especially high in this segment due to the frequency of diabetes diagnoses in dogs, as well as the larger size of dogs compared to cats, which may require higher doses of insulin and more frequent testing. Dogs’ diabetic care needs are diverse, ranging from routine blood sugar testing to the more sophisticated use of insulin pumps, and this demand for both basic and advanced devices helps drive growth in the market for pet diabetes care devices for dogs.
While horses represent a smaller segment of the pet diabetes care devices market, they are also impacted by diabetes, particularly in cases of insulin resistance, often related to metabolic disorders or obesity. Managing diabetes in horses can be more challenging due to their size and the complexity of their care needs. However, the growing awareness of diabetes in horses and the advancements in veterinary medicine are opening opportunities for specialized insulin delivery devices and continuous glucose monitoring systems. The use of insulin pumps and glucose meters is less common in horses compared to dogs and cats, but as more horse owners seek effective management strategies for chronic conditions like diabetes, there is potential for growth in the market. The veterinary care for horses tends to be more expensive and specialized, but increasing adoption of diabetes care devices is expected as horse owners prioritize better management and long-term health for their animals.
Global Pet Diabetes Care Devices Market, Segmentation by End-Use
The Global Pet Diabetes Care Devices Market has been segmented by End-Use into Veterinary clinics, Home care settings, and Veterinary hospitals.
The Global Pet Diabetes Care Devices Market is segmented by end-use into veterinary clinics, home care settings, and veterinary hospitals, each representing a different aspect of pet diabetes management. Veterinary clinics play a crucial role in the early diagnosis and ongoing management of diabetes in pets. These clinics are often the first point of contact for pet owners seeking diagnosis, treatment, and advice for their diabetic pets. In veterinary clinics, diabetes care devices such as glucose meters, insulin delivery devices, and diagnostic tools are commonly used to monitor and treat pets. The demand for these devices in veterinary clinics is driven by the need for accurate diagnoses, customized treatment plans, and regular monitoring of diabetic pets, making veterinary clinics an essential segment of the market. As more pet owners seek specialized care and diagnosis for chronic conditions like diabetes, the role of veterinary clinics in diabetes management will continue to expand, contributing to the growth of this segment.
In home care settings, there has been a significant shift towards managing pets’ diabetes at home, thanks to the growing availability of user-friendly, cost-effective diabetes care devices. Many pet owners now prefer to monitor and manage their pets' glucose levels and administer insulin injections at home, avoiding frequent vet visits. Devices such as home-use blood glucose meters, insulin pens, and syringes have become popular due to their convenience, accuracy, and affordability. This shift toward home care has been facilitated by advances in device technology that make it easier for pet owners to accurately monitor their pets' blood sugar levels and make necessary adjustments to their treatment plans. As more pet owners opt for home care solutions, the demand for diabetes care devices in home settings is likely to grow, offering pet owners flexibility and reducing the burden of frequent trips to the vet.
The veterinary hospitals segment, which includes specialized hospitals and large animal care centers, is another critical end-use market for pet diabetes care devices. Veterinary hospitals typically treat more complex or severe cases of pet diabetes, often involving specialized care, including insulin pumps, continuous glucose monitoring (CGM) systems, and more advanced diagnostic tools. These hospitals are equipped with the infrastructure and expertise to provide comprehensive diabetes management, including hospital-based treatments for acute diabetic crises, such as diabetic ketoacidosis, which may require intensive care. The demand for advanced diabetes care devices is higher in veterinary hospitals due to their focus on complex, critical cases and their ability to handle specialized equipment. As the quality and sophistication of veterinary hospitals continue to improve, especially in urban and developed regions, the market for diabetes care devices in these settings is expected to grow, further contributing to the overall expansion of the global pet diabetes care devices market.
Global Pet Diabetes Care Devices Market, Segmentation by Geography
In this report, the Global Pet Diabetes Care Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Pet Diabetes Care Devices Market Share (%), by Geographical Region, 2024
The Global Pet Diabetes Care Devices Market is segmented by geography into five key regions: North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America dominates the global market, primarily driven by the high awareness of pet health, increasing pet ownership, and a well-established veterinary infrastructure. In particular, the United States and Canada have seen a significant rise in the diagnosis of diabetes in pets, especially among cats and dogs, which has led to growing demand for diabetes care devices. North American pet owners are also increasingly adopting advanced diabetes management solutions, such as insulin pumps and continuous glucose monitors (CGMs), due to the high disposable income and the availability of these devices through both veterinary clinics and home care settings. Moreover, the presence of major market players and innovative veterinary care solutions further fuels the growth of the market in this region.
Europe follows closely in terms of market share, with countries such as the United Kingdom, Germany, France, and Italy seeing increasing adoption of diabetes care devices for pets. In Europe, the growing trend of pet humanization and heightened awareness about pet health, especially chronic conditions like diabetes, is driving demand for effective management solutions. The European market is characterized by a mix of advanced veterinary care and the growing availability of home-use devices for pet diabetes management. Countries with high levels of pet ownership and strong veterinary care systems are expected to see continued growth in the adoption of diabetes care devices. Additionally, the implementation of stricter regulations on pet healthcare and product safety in the European Union is encouraging the development of innovative diabetes management devices that meet regulatory standards, boosting market growth in the region.
The Asia Pacific region is experiencing rapid growth in the pet diabetes care devices market, primarily driven by increasing pet ownership in countries such as China, Japan, India, and South Korea. As the awareness of pet health improves and disposable income rises in emerging economies, pet owners in this region are increasingly willing to invest in advanced healthcare products for their pets. However, the market is still in a developing stage in many parts of Asia Pacific, with challenges including lower awareness of pet diabetes and the lack of access to specialized veterinary care. Despite these challenges, the demand for pet diabetes care devices is expected to rise as pet owners seek ways to manage their pets’ health more effectively, particularly in urban areas where the pet humanization trend is more pronounced. Meanwhile, the Middle East and Africa and Latin America are smaller markets, but they are gradually witnessing growth in pet diabetes care solutions. While adoption is slower due to limited veterinary care infrastructure and awareness, the increasing number of pet owners and growing interest in pet healthcare in these regions present promising opportunities for market expansion.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Pet Diabetes Care Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Prevalence of Diabetes in Pets
- Advancements in Pet Diabetes Care Technology
-
Growing Awareness of Pet Health and Wellness- The growing awareness of pet health and wellness is one of the key drivers for the Global Pet Diabetes Care Devices Market. Over the past decade, there has been a significant shift in how pet owners view their animals, with many now considering pets as family members rather than just animals. This cultural shift, often referred to as "pet humanization," has led to an increasing focus on the long-term health and well-being of pets. Pet owners today are more knowledgeable about pet diseases, preventative care, and chronic conditions such as diabetes, which has contributed to a higher demand for products and devices that help manage these health issues. As a result, the market for diabetes care devices, including glucose monitors, insulin pumps, and insulin delivery systems, has grown as more pet owners actively seek ways to improve their pets' quality of life and ensure they live healthy, happy lives.
The increasing availability of information through various channels, including social media, veterinary consultations, and pet health websites, has further amplified the awareness of pet health issues. Pet owners are now more informed about diseases like diabetes, recognizing the importance of early diagnosis and consistent monitoring. With diabetes becoming a more commonly diagnosed condition in pets, there is a greater understanding of the necessity of monitoring blood glucose levels and administering appropriate treatments such as insulin injections or pumps. The increased knowledge about the symptoms, risks, and long-term complications of untreated diabetes has made pet owners more proactive in seeking medical solutions, contributing to the demand for diabetes care devices designed specifically for pets. This shift in awareness has encouraged pet owners to invest in advanced medical devices, promoting the growth of the market.
The growing emphasis on preventive healthcare plays a significant role in the rising awareness of pet health. Pet owners are now more focused on not just treating health issues but also preventing them from occurring in the first place. Regular check-ups, proper nutrition, weight management, and the use of health-monitoring devices are increasingly becoming the norm for responsible pet ownership. With conditions like diabetes requiring continuous management to avoid complications, many pet owners are looking for ways to monitor and control their pets' health at home. This trend is driving the adoption of at-home diagnostic and monitoring tools, such as blood glucose meters and insulin delivery devices. As pet health continues to be a priority, the demand for innovative and accessible diabetes care devices is expected to rise, making this one of the key factors driving market growth.
Restraints:
- High Cost of Diabetes Care Devices
- Lack of Awareness in Developing Regions
-
Complexity of Usage- The complexity of usage is a significant restraint in the Global Pet Diabetes Care Devices Market, limiting the widespread adoption of diabetes care devices by pet owners. While there is growing demand for pet diabetes management solutions, many of the devices designed for glucose monitoring and insulin delivery can be complicated for pet owners to use effectively, especially those without prior medical experience. Devices such as continuous glucose monitors (CGMs), insulin pumps, and advanced blood glucose meters require a level of technical knowledge and familiarity with their operation, which may discourage some pet owners from adopting these solutions. The learning curve associated with these devices, including the proper calibration, accurate blood sample collection, and the administration of insulin, can be intimidating for many, leading them to hesitate in using these tools or opting for more traditional, albeit less efficient, methods of care.
For instance, insulin pumps, although highly effective in providing continuous insulin delivery, require careful programming and monitoring to ensure accurate dosages and to avoid complications such as over- or under-dosing. These devices also require regular maintenance, such as changing infusion sets and ensuring proper function, which can be overwhelming for pet owners who may not be familiar with medical equipment. Similarly, glucose monitoring devices, particularly continuous systems, require the proper placement of sensors on pets and careful tracking of glucose trends over time. The complexity of using these devices, coupled with the need for accurate interpretation of data, may result in pet owners being less confident in managing their pets' diabetes and more likely to seek professional care instead of using at-home solutions.
The lack of training and support also exacerbates the complexity issue. Many pet owners may not have access to the necessary resources to fully understand how to use diabetes care devices. While veterinarians can provide initial training, ongoing support and education are essential for ensuring proper device usage and troubleshooting. Without adequate guidance or technical support, some pet owners may struggle with using these devices correctly, which could lead to mismanagement of their pet's diabetes. This lack of support, combined with the inherent complexity of the devices, may result in suboptimal care, increasing the risk of complications for diabetic pets. As a result, pet owners may be less likely to adopt diabetes care devices or may eventually discontinue their use, representing a significant barrier to market growth.
Opportunities:
- Innovation in User-Friendly Devices
- Growth of Pet Insurance
-
Expansion into Emerging Markets- The expansion into emerging markets is a key opportunity for the Global Pet Diabetes Care Devices Market, as many regions with rapidly growing pet ownership and improving veterinary care infrastructure represent untapped potential. In countries across Asia Pacific, Latin America, and parts of Africa, the pet care industry is seeing significant growth. As disposable incomes rise, particularly in urban areas, more people are adopting pets, including cats and dogs, leading to an increased focus on pet health and wellness. In these regions, diabetes in pets is becoming a more recognized issue, and the demand for diabetes care devices is beginning to rise. However, the availability and affordability of such products remain limited, which creates a significant opportunity for market players to introduce cost-effective, user-friendly diabetes management solutions that are suitable for these markets.
Emerging markets often face challenges related to access to specialized veterinary care and healthcare infrastructure, which can limit the adoption of advanced diabetes care devices. However, as the veterinary sector in these regions continues to evolve, there is a growing opportunity to establish a strong presence. Veterinary professionals are increasingly trained to diagnose and treat diabetes in pets, and as awareness of pet health issues rises, there is a greater demand for home-based diabetes management solutions, such as glucose monitoring devices and insulin delivery systems. The availability of affordable devices that are easy to use and maintain will be crucial in driving market penetration in these regions, as many pet owners in emerging markets may not have access to regular veterinary care and prefer managing their pets' health at home.
As pet humanization continues to grow globally, emerging markets are seeing a shift in how pets are treated—transitioning from simply being pets to becoming integral members of the family. This cultural shift in pet care is driving an increasing willingness among pet owners in these regions to invest in their pets' health, including managing chronic conditions such as diabetes. As awareness about the importance of managing diabetes in pets increases, especially with the help of modern care devices, market players have the opportunity to cater to these evolving needs. Distribution channels, including online platforms and local pet care retail stores, can play a pivotal role in making these devices accessible to a wider audience. With the right strategic partnerships and pricing models, the pet diabetes care devices market can effectively expand into emerging markets and capitalize on this growing demand.
Competitive Landscape Analysis
Key players in Global Pet Diabetes Care Devices Market include,
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Device
- Market Snapshot, By Animal Type
- Market Snapshot, By End-Use
- Market Snapshot, By Region
- Global Pet Diabetes Care Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Prevalence of Diabetes in Pets
- Advancements in Pet Diabetes Care Technology
- Growing Awareness of Pet Health and Wellness
- Restraints
- High Cost of Diabetes Care Devices
- Lack of Awareness in Developing Regions
- Complexity of Usage
- Opportunities
- Innovation in User-Friendly Devices
- Growth of Pet Insurance
- Expansion into Emerging Markets
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Pet Diabetes Care Devices Market, By Device, 2021 - 2031 (USD Million)
- Insulin Delivery Devices
- Insulin Delivery Pen
- Insulin Syringes
- Glucose Monitoring Devices
- Global Pet Diabetes Care Devices Market, By Animal Type, 2021 - 2031 (USD Million)
- Cats
- Dogs
- Horses
- Global Pet Diabetes Care Devices Market, By End-Use, 2021 - 2031 (USD Million)
- Veterinary clinics
- Home care settings
- Veterinary hospitals
- Global Pet Diabetes Care Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Pet Diabetes Care Devices Market, By Device, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
- Company Profiles
- Analyst Views
- Future Outlook of the Market